Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | General Counsel | January 14, 2023 | January 18, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 14, 2023 · Filed January 18, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $4.43 · Expires 2033-01-14 | Direct | 125,000 |
Reported balance
After 2023-01-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-14 · Grant · Acquired 125,000 · Balance 125,000 F1: These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | Direct | 7,200 |
Reported balance
Holding disclosure · report date 2023-01-14 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,200 |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 14, 2023 Filed Jan 18, 2023 19:04 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 125,000 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-23-003556 · ownership.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2033-01-14 F1 · derivative.exercise_date: These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:10 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001213900-22-008936 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2032-02-18 F6 · derivative.exercise_date: These options were granted on 2/18/2022. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 19:52 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | Not disclosed | $0.00 Strike: $5.56 | $100,000.00 |
DisclosureSEC source: 0001213900-21-056529 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:03 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 140,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002052 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 19:08 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 2,525 | $4.03 | $10,175.75 |
DisclosureSEC source: 0001213900-20-022568 · doc4.xml · nonDerivative · entry 1 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:30 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 50,000 | $4.08 Strike: $4.08 | $204,000.00 |
DisclosureSEC source: 0001213900-20-012005 · doc4.xml · derivative · entry 3 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:30 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 50,000 | $5.63 Strike: $5.63 | $281,500.00 |
DisclosureSEC source: 0001213900-20-012005 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 16:18 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 3,250 | $3.05 | $9,912.50 |
DisclosureSEC source: 0001213900-20-006882 · doc4.xml · nonDerivative · entry 1 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,675 Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:47 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 24,764 | $5.63 Strike: $5.63 | $139,421.32 |
DisclosureSEC source: 0001213900-20-004979 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,764 Underlying: Common Stock · 24,764 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 17:24 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 1,425 | $7.04 | $10,037.56 |
DisclosureSEC source: 0001213900-20-000069 · doc4.xml · nonDerivative · entry 1 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,425 Read SEC document |
| May 01, 2019 Filed May 24, 2019 16:15 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 70,000 | $0.00 Strike: $7.92 | $0.00 |
DisclosureSEC source: 0001654954-19-006551 · section16.xml · derivative · entry 1 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2029-05-01 F1 · derivative.exercise_date: The options vest as follows: 42,000 vest equally over four years and 28,000 vest upon the achievement of designated milestones. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.